Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China flag China · Delayed Price · Currency is CNY
29.82
-0.03 (-0.10%)
Apr 21, 2026, 3:00 PM CST

SHA:688319 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
22.2620.7617.5626.58107.96
Depreciation & Amortization
37.7232.4730.8125.323.04
Other Amortization
5.343.533.153.431.64
Loss (Gain) From Sale of Assets
-0.010.030.150.150.01
Loss (Gain) From Sale of Investments
-0.5-0.86-1.04-3.7-3.76
Provision & Write-off of Bad Debts
13.2110.191.7212.189
Other Operating Activities
28.046.675.669.130.12
Change in Accounts Receivable
-84.65-83.630.98-151.92-147.16
Change in Inventory
9.71-13.571.68-7.96-27.28
Change in Accounts Payable
75.1319.06-12.364.4681.2
Operating Cash Flow
105.49-9.7344-24.5539.96
Operating Cash Flow Growth
----89.49%
Capital Expenditures
-98.81-207.32-169.88-200.69-69.71
Sale of Property, Plant & Equipment
0.030.03--0.01
Investment in Securities
-24.21-17.590140-190
Other Investing Activities
0.50.861.043.73.76
Investing Cash Flow
-122.49-223.93-78.84-56.99-255.94
Long-Term Debt Issued
176.1206.82208.25129.9935
Total Debt Issued
176.1206.82208.25129.9935
Long-Term Debt Repaid
-119.65-78.85-100.06-40-27.34
Total Debt Repaid
-119.65-78.85-100.06-40-27.34
Net Debt Issued (Repaid)
56.45127.97108.1989.997.66
Issuance of Common Stock
--10.3817.65371.81
Repurchase of Common Stock
-2.38-2.39---
Common Dividends Paid
-14.72-29.68-5.99-4.25-1.03
Other Financing Activities
-14.95-16.68--9.64
Financing Cash Flow
24.495.91129.27103.38368.79
Net Cash Flow
7.4-137.7694.4221.84152.82
Free Cash Flow
6.68-217.05-125.88-225.24-29.75
Free Cash Flow Margin
0.95%-36.86%-25.37%-41.14%-6.11%
Free Cash Flow Per Share
0.02-0.54-0.31-0.56-0.08
Cash Income Tax Paid
52.1425.5934.193516.56
Levered Free Cash Flow
13.44-200.57-140.57-198.44-67.11
Unlevered Free Cash Flow
22.81-191.53-136.09-195.27-66.34
Change in Working Capital
-0.57-82.52-14-97.61-98.05
Source: S&P Global Market Intelligence. Standard template. Financial Sources.